NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
Back to search
Official data from USPTO
NEW DAY BIORESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEW DAY BIORESEARCH
ST13
US500000098691539Class
35, 42
Filing
98691539
Registration
7815113
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/03/2025
Trademark type
Word
Nice classes
35, 42
Filing date
08/09/2024
Registration date
06/03/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/02/2024
First use in commerce
07/02/2024
Drawing code
4
Owner type
16
Owner location
Boca Raton, FL
Examiner
SWAIN, MICHELE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
New Day Diagnostics LLC
Representatives
Stephen P. McNamara St. Onge Steward Johnston & Reens LLC
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for approval of diagnostic devicestherapeutic devicesdrugs; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
Class 42
Clinical research in the field of diagnostic devices and diagnostic preparations; Consulting services for others in the field of designplanningimplementation project management of clinical studies of diagnostic devicestherapeutic devicesdrugs; Medical and scientific researchconducting clinical trials for others; Product development consulting in the field of diagnostic devicestherapeutic devicesdrugs; Providing information about medical research in the field of diagnostic devicestherapeutic devicesdrugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of diagnostic preparations; Scientific research in the nature of conducting clinical trials for others in the field of diagnostic devicestherapeutic devicesdrugs
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/24/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/24/2025
GNRT
NON-FINAL ACTION E-MAILED
02/24/2025
CNRT
NON-FINAL ACTION WRITTEN
02/24/2025
DOCK
ASSIGNED TO EXAMINER
02/18/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/22/2025
NWAP
NEW APPLICATION ENTERED
08/09/2024
Continuous trademark protection
Get notified about every new filing that threatens NEW DAY BIORESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.